Compare BP & SYK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BP | SYK |
|---|---|---|
| Founded | 1889 | 1941 |
| Country | United Kingdom | United States |
| Employees | 93700 | N/A |
| Industry | Integrated oil Companies | Medical/Dental Instruments |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 105.8B | 120.7B |
| IPO Year | N/A | 1994 |
| Metric | BP | SYK |
|---|---|---|
| Price | $43.32 | $352.25 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 11 | 14 |
| Target Price | $44.43 | ★ $415.57 |
| AVG Volume (30 Days) | ★ 8.3M | 2.0M |
| Earning Date | 04-28-2026 | 04-30-2026 |
| Dividend Yield | ★ 4.18% | 1.12% |
| EPS Growth | N/A | ★ 8.25 |
| EPS | N/A | ★ 1.93 |
| Revenue | N/A | ★ $25,116,000,000.00 |
| Revenue This Year | $13.52 | $9.80 |
| Revenue Next Year | N/A | $8.44 |
| P/E Ratio | $11,332.35 | ★ $178.77 |
| Revenue Growth | N/A | ★ 11.16 |
| 52 Week Low | $31.59 | $281.00 |
| 52 Week High | $48.27 | $401.99 |
| Indicator | BP | SYK |
|---|---|---|
| Relative Strength Index (RSI) | 59.76 | 64.60 |
| Support Level | $42.21 | $348.46 |
| Resistance Level | $44.14 | $352.80 |
| Average True Range (ATR) | 0.68 | 8.72 |
| MACD | 0.32 | 2.58 |
| Stochastic Oscillator | 81.17 | 95.00 |
BP is an integrated energy company that explores for, produces, and refines oil and gas around the world. In 2025, it produced 1.2 million barrels of liquids and 6.5 billion cubic feet of natural gas per day. At the end of 2025, proved hydrocarbon reserves stood at 6.2 billion barrels of oil equivalent, 56% of which are liquids. The company operates refineries with a total crude distillation capacity of 1.56 million barrels of oil per day.
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one-fourth of Stryker's total revenue currently comes from outside the United States.